Prostate Cancer and Prostatic Diseases - Table of Contents alert Volume 17 Issue 2

If you are unable to see the message below, click here to view.

TABLE OF CONTENTS Volume 17, Issue 2 (June 2014) In this issue Reviews Original Articles Corrigendum Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement Cancer Gene Therapy wants to publish your paper Get your research the exposure and recognition it deserves when you submit your paper to Cancer Gene Therapy. Be a part of this growing community and benefit from: - High exposure through Nature.com - Competitive turnaround times - Open access option - Inclusion in the leading abstracting and indexing services Submit your research today.   Reviews Top Intermittent androgen deprivation is a rational standard-of-care treatment for all stages of progressive prostate cancer: results from a systematic review and meta-analysis D Brungs, J Chen, P Masson and R J Epstein Prostate Cancer Prostatic Dis 2014 17: 105-111; advance online publication, April 1, 2014; 10.1038/pcan.2014.10 Abstract | Full Text Novel bone-targeting agents in prostate cancer C Albany and N M Hahn Prostate Cancer Prostatic Dis 2014 17: 112-118; advance online publication, March 25, 2014; 10.1038/pcan.2014.12 Abstract | Full Text Original Articles Top Upregulation of RASGRP3 expression in prostate cancer correlates with aggressive capabilities and predicts biochemical recurrence after radical prostatectomy OPEN X Zeng, Z Hu, Z Wang, J Tao, T Lu, C Yang, B Lee and Z Ye Prostate Cancer Prostatic Dis 2014 17: 119-125; advance online publication, January 14, 2014; 10.1038/pcan.2013.51 Abstract | Full Text ERG rearrangement and protein expression in the progression to castration-resistant prostate cancer J R Gsponer, M Braun, V J Scheble, T Zellweger, A Bachmann, S Perner, T Vlajnic, M Srivastava, S-H Tan, A Dobi, I A Sesterhenn, S Srivastava, L Bubendorf and C Ruiz Prostate Cancer Prostatic Dis 2014 17: 126-131; advance online publication, January 28, 2014; 10.1038/pcan.2013.62 Abstract | Full Text The effect of testosterone replacement therapy on prostate cancer: a systematic review and meta-analysis Y Cui, H Zong, H Yan and Y Zhang Prostate Cancer Prostatic Dis 2014 17: 132-143; advance online publication, January 21, 2014; 10.1038/pcan.2013.60 Abstract | Full Text The association of tumor volume with mortality following radical prostatectomy J J Knoedler, R J Karnes, R H Thompson, L J Rangel, E J Bergstralh and S A Boorjian Prostate Cancer Prostatic Dis 2014 17: 144-148; advance online publication, January 28, 2014; 10.1038/pcan.2013.61 Abstract | Full Text Genetic variants in the CYP24A1 gene are associated with prostate cancer risk and aggressiveness in a Korean study population J J Oh, S-S Byun, S E Lee, S K Hong, C W Jeong, W S Choi, D Kim, H J Kim and S C Myung Prostate Cancer Prostatic Dis 2014 17: 149-156; advance online publication, February 4, 2014; 10.1038/pcan.2014.1 Abstract | Full Text Left lobe of the prostate during clinical prostate cancer screening: the dark side of the gland for right-handed examiners G Ploussard, N Nicolaiew, P Mongiat-Artus, S Terry, Y Allory, F Vacherot, C-C Abbou, F Desgrandchamps, L Salomon and A de la Taille Prostate Cancer Prostatic Dis 2014 17: 157-162; advance online publication, February 11, 2014; 10.1038/pcan.2014.2 Abstract | Full Text Specialty bias in treatment recommendations and quality of life among radiation oncologists and urologists for localized prostate cancer S P Kim, C P Gross, P Y Nguyen, M C Smaldone, R H Thompson, N D Shah, A Kutikov, L C Han, R J Karnes, J Y Ziegenfuss and J C Tilburt Prostate Cancer Prostatic Dis 2014 17: 163-169; advance online publication, February 25, 2014; 10.1038/pcan.2014.3 Abstract | Full Text The role of transperineal template prostate biopsies in prostate cancer diagnosis in biopsy naïve men with PSA less than 20 ng ml−1 S Nafie, J K Mellon, J P Dormer and M A Khan Prostate Cancer Prostatic Dis 2014 17: 170-173; advance online publication, March 4, 2014; 10.1038/pcan.2014.4 Abstract | Full Text A risk-adjusted definition of biochemical recurrence after radical prostatectomy T M Morgan, M V Meng, M R Cooperberg, J E Cowan, V Weinberg, P R Carroll and D W Lin Prostate Cancer Prostatic Dis 2014 17: 174-179; advance online publication, March 11, 2014; 10.1038/pcan.2014.5 Abstract | Full Text A double-blind, placebo-controlled randomised trial evaluating the effect of a polyphenol-rich whole food supplement on PSA progression in men with prostate cancer—the UK NCRN Pomi-T study OPEN R Thomas, M Williams, H Sharma, A Chaudry and P Bellamy Prostate Cancer Prostatic Dis 2014 17: 180-186; advance online publication, March 11, 2014; 10.1038/pcan.2014.6 Abstract | Full Text Prostate cancer incidence and mortality in the Spanish section of the European Randomized Study of Screening For Prostate Cancer (ERSPC) M Luján, A Páez, J C Angulo, R Granados, M Nevado, G M Torres and A Berenguer Prostate Cancer Prostatic Dis 2014 17: 187-191; advance online publication, March 11, 2014; 10.1038/pcan.2014.7 Abstract | Full Text Androgen dynamics and serum PSA in patients treated with abiraterone acetate OPEN C J Ryan, W Peng, T Kheoh, E Welkowsky, C M Haqq, D W Chandler, H I Scher and A Molina Prostate Cancer Prostatic Dis 2014 17: 192-198; advance online publication, March 18, 2014; 10.1038/pcan.2014.8 Abstract | Full Text Ganglioside disialosyl globopentaosylceramide is an independent predictor of PSA recurrence-free survival following radical prostatectomy S Shimada, A Ito, Y Kawasaki, N Kakoi, T Taima, K Mitsuzuka, M Watanabe, S Saito and Y Arai Prostate Cancer Prostatic Dis 2014 17: 199-205; advance online publication, March 18, 2014; 10.1038/pcan.2014.9 Abstract | Full Text Prostate cancer diagnosis through electronic nose in the urine headspace setting: a pilot study A D Asimakopoulos, D Del Fabbro, R Miano, M Santonico, R Capuano, G Pennazza, A D'Amico and E Finazzi-Agrò Prostate Cancer Prostatic Dis 2014 17: 206-211; advance online publication, April 1, 2014; 10.1038/pcan.2014.11 Abstract | Full Text Corrigendum Top Specialty bias in treatment recommendations and quality of life among radiation oncologists and urologists for localized prostate cancer S P Kim, C P Gross, P Y Nguyen, M C Smaldone, R H Thompson, N D Shah, A Kutikov, L C Han, R J Karnes, J Y Ziegenfuss and J C Tilburt Prostate Cancer Prostatic Dis 2014 17: 212; advance online publication, April 8, 2014; 10.1038/pcan.2014.14 Full Text Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Prostate Cancer and Prostatic Diseases. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2014 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.